Prevalence of anti-HLA antibodies in COVID-19 convalescent plasma donors: an Indian experience

Background: COVID-19 convalescent plasma is one of the experimental therapies used widely in moderately sick COVID-19 patients. However, there are a few risks involved in plasma transfusion; notably, transfusion-related acute lung injury (TRALI) caused by antibodies against human leukocyte antigens...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Ram Mohan Jaiswal, Aseem Kumar Tiwari, Ashina Singla, Ashish Jain, Rajaat Vohra, Munish Kakkar, Prashanth Suravajhala
Format:	Artigo
Język:	Inglês
Wydane:	Elsevier 2024-10-01
Seria:	Hematology, Transfusion and Cell Therapy
Hasła przedmiotowe:	Anti HLA antibody TRALI CCP
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S2531137924002207
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!